![Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients | Semantic Scholar Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/18950be49212ec48fce11748d4121fa591d3b70c/1-Figure1-1.png)
Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients | Semantic Scholar
Induction of a higher-ordered architecture in glatiramer acetate improves its biological efficiency in an animal model of multiple sclerosis - Biomaterials Science (RSC Publishing)
![Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: A clinicopathologic and immunohistochemical study - Journal of the American Academy of Dermatology Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: A clinicopathologic and immunohistochemical study - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5c60cc76-44be-4061-92c2-3edaf2b03869/gr1.jpg)
Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: A clinicopathologic and immunohistochemical study - Journal of the American Academy of Dermatology
![Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD - Multiple Sclerosis and Related Disorders Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e0bb6a8f-8409-433f-a10e-cd8b10e52568/gr1.jpg)